Efficacy of rechallenge transcatheter arterial chemoembolization after lenvatinib treatment for advanced hepatocellular carcinoma.

MLA

Uchida, Kobayashi, Sawako, et al. “Efficacy of Rechallenge Transcatheter Arterial Chemoembolization after Lenvatinib Treatment for Advanced Hepatocellular Carcinoma.” JGH Open, vol. 6, no. 11, Nov. 2022, pp. 754–62. EBSCOhost, https://doi.org/10.1002/jgh3.12819.

APA

Uchida, K. S., Kageyama, K., Takemura, S., Matsumoto, K., Odagiri, N., Jogo, A., Kotani, K., Kozuka, R., Motoyama, H., Kawamura, E., Hagihara, A., Yamamoto, A., Fujii, H., Tanaka, S., Enomoto, M., Tamori, A., Miki, Y., Kubo, S., & Kawada, N. (2022). Efficacy of rechallenge transcatheter arterial chemoembolization after lenvatinib treatment for advanced hepatocellular carcinoma. JGH Open, 6(11), 754–762. https://doi.org/10.1002/jgh3.12819

Chicago

Uchida, Kobayashi, Sawako, Ken Kageyama, Shigekazu Takemura, Kazuhiro Matsumoto, Naoshi Odagiri, Atsushi Jogo, Kohei Kotani, et al. 2022. “Efficacy of Rechallenge Transcatheter Arterial Chemoembolization after Lenvatinib Treatment for Advanced Hepatocellular Carcinoma.” JGH Open 6 (11): 754–62. doi:10.1002/jgh3.12819.